| Literature DB >> 32256948 |
Simona Mrakic-Sposta1, Maristella Gussoni2, Alessandra Vezzoli1, Cinzia Dellanoce1, Mario Comassi3, Guido Giardini4, Rosa Maria Bruno5, Michela Montorsi6, Anca Corciu3, Fulvia Greco2, Lorenza Pratali3.
Abstract
The response to strenuous exercise was investigated by reactive oxygen species (ROS) production, oxidative damage, thiol redox status, and inflammation assessments in 32 enrolled triathlon athletes (41.9 ± 7.9 yrs) during Ironman® (IR), or half Ironman® (HIR) competition. In biological samples, inflammatory cytokines, aminothiols (glutathione (GSH), homocysteine (Hcy), cysteine (Cys), and cysteinylglycine (CysGly)), creatinine and neopterin, oxidative stress (OxS) biomarkers (protein carbonyl (PC), thiobarbituric acid-reactive substances (TBARS)), and ROS were assessed. Thirteen HIR and fourteen IR athletes finished the race. Postrace, ROS (HIR +20%; IR +28%; p < 0.0001), TBARS (HIR +57%; IR +101%), PC (HIR +101%; IR +130%) and urinary neopterin (HIR +19%, IR +27%) significantly (range p < 0.05-0.0001) increased. Moreover, HIR showed an increase in total Cys +28%, while IR showed total aminothiols, Cys, Hcy, CysGly, and GSH increase by +48, +30, +58, and +158%, respectively (range p < 0.05-0.0001). ROS production was significantly correlated with TBARS and PC (R 2 = 0.38 and R 2 = 0.40; p < 0.0001) and aminothiols levels (range R 2 = 0.17-0.47; range p < 0.01-0.0001). In particular, ROS was directly correlated with the athletes' age (R 2 = 0.19; p < 0.05), with ultraendurance years of training (R 2 = 0.18; p < 0.05) and the days/week training activity (R 2 = 0.16; p < 0.05). Finally, the days/week training activity (hours/in the last 2 weeks) was found inversely correlated with the IL-6 postrace (R 2 = -0.21; p < 0.01). A strenuous performance, the Ironman® distance triathlon competition, alters the oxidant/antioxidant balance through a great OxS response that is directly correlated to the inflammatory parameters; furthermore, the obtained data suggest that an appropriate training time has to be selected in order to achieve the lowest ROS production and IL-6 concentration at the same time.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32256948 PMCID: PMC7109587 DOI: 10.1155/2020/3062807
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Figure 1Experimental protocol adopted to measure the OxS parameters on the biological samples collected from the Elbaman (IR) and Elbaman 73 (HIR) selected participants.
Anthropometric and physiological parameters from the HIR and IR subjects who ended the race collected at PRE and POST measurement sessions.
| HIR | IR | |||||
|---|---|---|---|---|---|---|
| PRE | POST |
| PRE | POST |
| |
| Weight (kg) | 71.2 ± 7.4 | 69.5 ± 7.7 | <0.0001 | 70.2 ± 5.5 | 68.2 ± 5.1 | 0.0002 |
| BMI (kg·m−2) | 23.4 ± 1.9 | 22.8 ± 2.0 | <0.0001 | 22.9 ± 1.4 | 22.3 ± 1.3 | ns |
| FM (kg) | 5.3 ± 2.7 | 5.5 ± 2.4 | ns | 5.1 ± 2.5 | 5.5 ± 2.0 | ns |
| FFM (kg) | 66.1 ± 5.9 | 64.1 ± 6.0 | <0.0001 | 65.1 ± 5.6 | 62.7 ± 5.8 | <0.0001 |
| TBW (%) | 48.2 ± 4.3 | 47.0 ± 4.4 | <0.0001 | 47.6 ± 4.1 | 45.9 ± 3.5 | <0.0001 |
| HR (bpm) | 60.5 ± 8.7 | 85.2 ± 17.2 | 0.0002 | 59.1 ± 17.4 | 80.8 ± 14.2 | 0.0039 |
| SBP (mmHg) | 125.5 ± 23.4 | 141.2 ± 11.5 | ns | 123.7 ± 16.9 | 138.4 ± 12.3 | ns |
| DBP (mmHg) | 72.5 ± 13.5 | 81.2 ± 6.4 | ns | 72.5 ± 10.7 | 79.5 ± 16.7 | ns |
| SaO2 (%) | 97.8 ± 0.6 | 96.6 ± 1.3 | ns | 97.6 ± 0.9 | 97.4 ± 1.5 | ns |
BMI: body mass index; FM: fat mass; FFM: fat-free mass; TBW: total body water; HR: heart rate; SBP: systolic blood pressure; DBP: diastolic blood pressure; SaO2: arterial oxygen saturation (%). Data are reported as the mean ± SD. ns: not significant level.
White blood cell (WBC) count (103/μL) and inflammatory markers: IL-1β, IL-6, IL-10, TNF-α, and MCP-1 (pg/mL), determined at PRE and POST sessions from HIR and IR athletes. Data are reported as the mean ± SD. The types of leukocytes, classified in the standard ways, are reported as a percentage (%) of the total WBC together with the significance levels (POST vs. PRE).
| HIR | IR | |||||
|---|---|---|---|---|---|---|
| PRE | POST |
| PRE | POST |
| |
| WBC (103/ | 6.45 ± 3.29 | 14.27 ± 3.19 | <0.05 | 5.23 ± 0.83 | 16.85 ± 2.37 | <0.05 |
| Leukocytes (%) | ||||||
| Neutrophils | 60 | 77 | <0.0001 | 58 | 78 | <0.0001 |
| Eosinophils | 2.3 | 3 | ns | 2.2 | 2.7 | ns |
| Basophiles | 0.4 | 0.5 | ns | 0.4 | 0.5 | ns |
| Lymphocytes | 31 | 11 | <0.05 | 33.5 | 11.4 | <0.05 |
| Monocytes | 6.6 | 8.5 | 0.0013 | 5.8 | 7 | <0.0001 |
| ∗Inflammatory markers (pg/mL) | ||||||
| IL-1 | 17.7 ± 16.5 | 30.2 ± 47.0 | <0.05 | 20.9 ± 17.1 | 25.3 ± 21.7 | ns |
| IL-6 | 8.9 ± 18.8 | 18.9 ± 13.7 | <0.05 | 4.2 ± 2.7 | 18.9 ± 13.1 | <0.05 |
| IL-10 | 14.2 ± 19.2 | 35.0 ± 32.8 | <0.05 | 11.5 ± 6.6 | 63.5 ± 65.9 | <0.05 |
| TNF- | 19.0 ± 30.0 | 19.0 ± 18.9 | ns | 10.9 ± 4.3 | 12.7 ± 3.1 | ns |
| MCP-1 | 312 ± 139 | 852 ± 284 | <0.05 | 337 ± 165 | 1116 ± 598 | <0.05 |
∗Inflammatory marker data were previously reported by some of us [34].
Figure 2Plots of the (a) ROS production rate (μmol·min−1); (b) TBARS (μM), and (c) PC (nmol·mg−1 protein) data collected from the HIR (empty square) and IR (full square) groups. Data are expressed as the mean ± SD. The lines connecting PRE and POST data are displayed as guide for the eyes. Changes over time (POST vs. PRE) were significant at ¶p < 0.0001.
Aminothiol redox status measured in plasma and red blood cells (RBCs) on HIR and IR athletes before (PRE) and immediately after (POST) the race. Concentrations of the various forms are expressed as μmol·L−1.
| Plasma | HIR | IR | ||||
|---|---|---|---|---|---|---|
| PRE | POST |
| PRE | POST |
| |
| Cysteine | ||||||
| Total | 239.42 ± 17.81 | 305.36 ± 26.11 | <0.0001 | 213.51 ± 31.28 | 351.38 ± 50.19 | 0.0007 |
| Reduced | 10.08 ± 1.01 | 12.79 ± 1.73 | ns | 9.15 ± 2.77 | 13.92 ± 4.04 | ns |
| Oxidized | 229.34 ± 18.14 | 292.57 ± 25.99 | <0.0001 | 204.35 ± 30.04 | 337.45 ± 47.45 | 0.0006 |
| Homocysteine | ||||||
| Total | 6.95 ± 0.87 | 8.19 ± 0.76 | ns | 6.91 ± 0.79 | 8.99 ± 1.61 | 0.0147 |
| Reduced | 0.10 ± 0.04 | 0.16 ± 0.03 | ns | 0.10 ± 0.04 | 0.19 ± 0.06 | ns |
| Cysteinylglycine | ||||||
| Total | 29.66 ± 3.06 | 40.90 ± 5.13 | ns | 27.35 ± 3.00 | 43.24 ± 6.25 | 0.0004 |
| Reduced | 2.34 ± 0.32 | 2.71 ± 0.31 | ns | 2.78 ± 0.68 | 3.17 ± 0.75 | ns |
| Oxidized | 27.31 ± 2.91 | 38.19 ± 5.18 | ns | 24.56 ± 2.68 | 40.07 ± 5.92 | 0.0004 |
| Glutathione | ||||||
| Total | 6.22 ± 1.16 | 8.18 ± 1.15 | ns | 6.47 ± 0.54 | 16.73 ± 1.86 | <0.0001 |
| Reduced | 0.92 ± 0.37 | 0.92 ± 0.39 | ns | 0.57 ± 0.25 | 0.70 ± 0.49 | ns |
| Oxidized | 5.30 ± 1.31 | 7.26 ± 1.26 | ns | 5.90 ± 0.54 | 16.03 ± 1.59 | <0.0001 |
| RBCs | ||||||
|
| ||||||
| Total | 64.67 ± 8.61 | 74.69 ± 9.23 | ns | 62.16 ± 7.67 | 72.21 ± 8.89 | ns |
| Reduced | 10.45 ± 1.45 | 10.85 ± 1.53 | ns | 11.13 ± 1.77 | 11.94 ± 1.79 | ns |
| Oxidized | 54.22 ± 8.23 | 63.84 ± 9.00 | ns | 51.03 ± 7.07 | 60.27 ± 8.46 | ns |
| Homocysteine | ||||||
| Total | 2.94 ± 0.39 | 3.11 ± 0.43 | ns | 2.61 ± 0.20 | 3.06 ± 0.29 | ns |
| Reduced | 1.17 ± 0.11 | 1.09 ± 0.13 | ns | 1.14 ± 0.17 | 1.19 ± 0.27 | ns |
| Cysteinylglycine | ||||||
| Total | 2.16 ± 0.44 | 2.51 ± 0.34 | ns | 2.17 ± 0.41 | 2.53 ± 0.27 | ns |
| Reduced | 0.47 ± 0.37 | 0.62 ± 0.31 | ns | 0.56 ± 0.17 | 0.66 ± 0.16 | ns |
| Oxidized | 1.69 ± 0.73 | 1.89 ± 0.38 | ns | 1.61 ± 0.46 | 1.87 ± 0.35 | ns |
| Glutathione | ||||||
| Total | 1691.46 ± 134.29 | 1957.69 ± 194.03 | <0.0001 | 1870.35 ± 211.98 | 2160.42 ± 181.61 | <0.0001 |
| Reduced | 1507.52 ± 141.05 | 1677.72 ± 168.83 | <0.0001 | 1681.73 ± 244.14 | 1865.54 ± 219.23 | <0.0001 |
| Oxidized | 183.93 ± 58.56 | 279.98 ± 71.24 | ns | 188.62 ± 57.34 | 294.88 ± 96.32 | ns |
Figure 3Neopterin concentrations (μmol·mol−1 creatinine) measured from the HIR (empty and grey bars) and IR (full bars) athletes. Results are expressed as the mean ± SD. Significantly different data are displayed between brackets. Changes over time (POST vs. PRE) were significant at ∗p < 0.05, #p < 0.01, and §p < 0.001.
Correlation coefficients (R2) and p significance levels between biochemical-hematological and OxS-selected parameters determined from all the athletes.
| Biochemical-hematological parameters | ||||||
|---|---|---|---|---|---|---|
| ROS |
| TBARS |
| PC |
| |
| Na (mEq/L) |
| 0.0142 | — | ns | — | ns |
| Osmolarity (mOsm/L) |
| <0.0001 |
| 0.012 |
| <0.0001 |
| Ferritin (ng/mL) | — | ns | — | ns | — | ns |
| Transferrin (mg/dL) | — | ns | — | ns | — | ns |
| Hb (g/dL) |
| 0.0132 | — | ns | — | ns |
| MCV ( | — | ns | — | ns | — | ns |
| Platelets (109/ | — | ns |
| <0.0001 |
| 0.0021 |
| Neutrophils (103/ |
| 0.0023 |
| <0.0001 |
| <0.0001 |
| Eosinophils (103/ | — | ns | — | ns | — | ns |
| Lymphocyte (103/ |
| <0.0001 |
| <0.0001 |
| <0.0001 |
| Monocytes (103/ | — | ns | — | ns | — | ns |
| HDL cholesterol (mmol/L) |
| 0.0002 |
| 0.0120 | — | ns |
| Urea (mg/dL) |
| <0.0001 |
| <0.0001 |
| <0.0001 |
| Uric acid (mg/dL) |
| <0.0001 |
| 0.0002 |
| <0.0001 |
Figure 4Panel plot showing the individual ROS production rate concentration values (μmol·min−1) plotted versus the following: (a) TBARS (μM); (b) PC (nmol·mg−1 protein); (c) total, (d) reduced, and (e) oxidized Cys (μmol·L−1); (f) total and (g) reduced Hcy (μmol·L−1); (h) total, (i) reduced, and (j) oxidized CysGly (μmol·L−1); (k) total and (l) oxidized glutathione (μmol·L−1) values obtained in HIR athletes at PRE (empty square) and POST (light grey square) and in IR athletes at PRE (dark grey square) and POST (black square). The linear regression lines (solid lines) and the correlation coefficients (R2) are reported in each panel. Significant relationships: #p < 0.01, §p < 0.001, and ¶p < 0.0001.
Figure 5Panel plot showing the lymphocyte count (103/μL) versus cytokine (a) IL-6 and (b) IL-10 concentrations (pg/mL) obtained from HIR subjects at PRE (empty square) and POST (light grey square) and from IR subjects at PRE (dark grey square) and POST (black square). The linear regression lines (solid lines) and the correlation coefficients (R2) are reported in each panel. Significant relationships: #p < 0.01.